Skip to main content

Table 1 Inclusion criteria

From: Prognostic value of patient-reported outcome measures in adult heart-transplant patients: a systematic review

Population: heart transplant patients > 18 years old
Intervention: generic and disease specific instruments developed, validated and tested for measuring patient-reported outcomes
Primary outcomes:
Survival rates at 1 month, 6 months, 1 year
Readmissions at 1 month, 6 months, 1 year
Secondary outcomes:
Proportion of heart transplant complications: infections, graft vascular disease, organ rejection, etc
Proportion of onset of new comorbidities
Studies: Randomized clinical trials, observational studies such as case series and case reports involving >  = 10 patients, case–control studies, and cohort studies